Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Viking Therapeutics (VKTX) Shares Outstanding: 2014-2024

Historic Shares Outstanding for Viking Therapeutics (VKTX) over the last 11 years, with Dec 2024 value amounting to $111.6 million.

  • Viking Therapeutics' Shares Outstanding rose 0.91% to $112.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $112.4 million, marking a year-over-year increase of 0.91%. This contributed to the annual value of $111.6 million for FY2024, which is 11.45% up from last year.
  • As of FY2024, Viking Therapeutics' Shares Outstanding stood at $111.6 million, which was up 11.45% from $100.1 million recorded in FY2023.
  • In the past 5 years, Viking Therapeutics' Shares Outstanding ranged from a high of $111.6 million in FY2024 and a low of $73.2 million during FY2020.
  • For the 3-year period, Viking Therapeutics' Shares Outstanding averaged around $96.6 million, with its median value being $100.1 million (2023).
  • Data for Viking Therapeutics' Shares Outstanding shows a peak YoY rose of 27.93% (in 2023) over the last 5 years.
  • Viking Therapeutics' Shares Outstanding (Yearly) stood at $73.2 million in 2020, then climbed by 6.87% to $78.2 million in 2021, then increased by 0.01% to $78.3 million in 2022, then climbed by 27.93% to $100.1 million in 2023, then climbed by 11.45% to $111.6 million in 2024.